IFNAR1 and infection: On the other hand, serum obtained at 6 dpc using a late ZIKV-challenge 28 days after initial vaccination, completely protected IFNAR-/- mice from ZIKV-challenge, suggesting that nAb-responses likely play a critical role in protection at the later stages of infection.